Rafael Rosell, MD, PhD
Chief, Medical Oncology Service
Scientific Director of Oncology Research
Catala Institute of Oncology
Hospital Germans Trias i Pujol
Barcelona, Spain
Ramesh K. Ramanathan, MD
Medical Director,
TGen Clinical Research Service
at Scottsdale Health Care,
Scottsdale, AZ
Clinical Professor of Medicine,
College of Medicine,
University of Arizona,
Phoenix, AZ
Other Expert Faculty
Svetomir N. Markovic, MD, PhD
Associate Professor of Oncology
Professor of Medicine
Mayo Clinic
Rochester, MN
Jeffrey R. Infante, MD
Associate Director of Drug Development
Sarah Cannon Research Institute
Nashville, TN
CO-CHAIRS
Rafael Rosell, MD, PhD
Chief, Medical Oncology Service
Scientific Director of Oncology Research
Catala Institute of Oncology
Hospital Germans Trias i Pujol
Barcelona, Spain
Ramesh K. Ramanathan, MD
Medical Director,
TGen Clinical Research Service at Scottsdale Health Care,
Scottsdale, AZ
Clinical Professor of Medicine,
College of Medicine,
University of Arizona,
Phoenix, AZ
Using Biomarkers to Maximize Novel Taxane Therapies in Multiple Tumor Types: Case-Based Learning
May 30, 2009 - Saturday
6:00PM – 6:30PM
Dinner Reception and Registration
6:30PM – 6:35PM
Welcome and Introduction
Rafael Rosell
6:35PM – 6:40PM
CME pre test
Rafael Rosell
6:40PM – 6:55PM
Case Study #1: A previously untreated patient with advanced pancreatic cancer tested for CA 19-9 and SPARC
Audience selects treatment and patient care options with the use of an audience response system (ARS). Treatment and patient care options are based upon patient characteristics contained in this case.
Ramesh Ramanathan presents additional key data.
Ramesh K. Ramanathan
6:55PM – 7:05PM
Expert faculty answers questions from the audience.
All Faculty
7:05PM – 7:20PM
Case Study #2: A previously untreated patient with metastatic non-small cell lung cancer of adenocarcinoma histology, tested for the EGFR mutation, ERCC1, RRM1, and thymidylate synthase
Audience selects treatment and patient care options with the use of an audience response system (ARS). Treatment and patient care options are based upon patient characteristics contained in this case.
Rafael Rosell presents additional key data.
Rafael Rosell
7:20PM – 7:30PM
Expert faculty answers questions from the audience.
All Faculty
7:30PM – 7:45PM
Case Study #3: A patient with locally advanced, early-stage breast cancer, tested for ER/PR, HER2, SPARC, the 21 genomic assay panel, and the 70-gene micro array
Audience selects treatment and patient care options with the use of an audience response system (ARS). Treatment and patient care options are based upon patient characteristics contained in this case.
Jeffrey R. Infante presents additional key data.
Jeffrey R. Infante
7:45PM – 7:55PM
Expert faculty answers questions from the audience.
All Faculty
7:55PM – 8:10PM
Case Study #4: A patient with unresectable Stage IV metastatic melanoma tested for SPARC
Audience selects treatment and patient care options with the use of an audience response system (ARS). Treatment and patient care options are based upon patient characteristics contained in this case.
Svetomir Markovic presents additional key data.
Svetomir N. Markovic
8:10PM – 8:25PM
Expert faculty answers questions from the audience.
All Faculty
8:25PM – 8:30PM
CME post test
Ramesh K. Ramanathan
8:30PM
Adjourn
Educational Grant
Sincere appreciation is extended to Abraxis Oncology for their generous support of this educational meeting.
Contact Us
Oncology Learning Center 16415 Addison Rd., Suite 300
Addison, TX 75001 (214) 269 2014
1415 Legacy Drive, Suite 250 • Frisco, TX 75034 • Registration Phone: 214.269.2014 • Fax: 214.866.0311 Contact Us
Disclaimer: The material published on the Biomedical Learning Institute(BLI) Web site reflects the opinions and expertise of the authors and/or reviewers of the material, and not the opinions of the BLI, the CME provider, or the commercial supporters providing educational grants. The materials may address uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. Before using any therapeutic approaches reviewed in this material, a qualified physician should be consulted. Readers of this content should verify all information and data before treating patients or using any drugs or therapies described in any BLI materials. Click here for our Privacy Policy.
